According to the chain drug stores ranking in China in 2009, top 100 enterprises in China pharmaceutical chain industry achieved the sales revenue of RMB57.24 billion in 2008, increasing by RMB13.33 billion (30.35%) than RMB43.91 billion in 2007.
In 2008, the average profit margin of top 100 enterprises was 3.76%, more 0.76 points than that in 2007
The data of this report come from China Association of Pharmaceutical Commerce, www.pharmnet.com.cn, www.ydzz.com and the National Bureau of Statistics of China. The report makes an in-depth analysis of the operation and future development of pharmaceutical chain industry, guiding investment and financing decision-making.
This report includes 8 chapters and 65 diagrams, covering all major aspects and key enterprises in China pharmaceutical chain industry. Chapter 1 introduces the development of China pharmaceutical chain industry briefly. Chapter 2 analyzes the macroeconomic environment, industry environment and policies related with China pharmaceutical chain industry. Chapter 3, 4, 5 analyze operation, competition patterns and key areas of China pharmaceutical chain industry, such as market scale, profitability, competition patterns and regional difference. Chapter 6 analyzes the development trends of China pharmaceutical chain industry. Finally, Chapter 7 analyzes the development, revenue distribution and profitability of over 10 key Chinese pharmaceutical enterprises, including LBX Pharmacy, Nepstar, Hubei Tongjitang, Chongqing Tongjunge Pharmacy, Sinopharm Group Co., Ltd., Chongqing Peace Drugstore.
Copyright by FriedlNet.com
To get more information, please contact us:
Friedl Business Information GmbH
Business & Research Center
Meldemannstrasse 18/EG08+09
1200 Vienna, Austria
Tel: (+43-1) 3218888-0
Fax: (+43-1) 3218888-8
Website: http://www.friedlnet.com
Email: rc@friedlnet.com
